APA

Kaifer K. A., Villalón E., O'Brien B. S., Sison S. L., Smith C. E., Simon M. E., Marquez J., O'Day S., Hopkins A. E., Neff R., Rindt H., Ebert A. D. & Lorson C. L. (20200511). AAV9-mediated delivery of miR-23a reduces disease severity in Smn2B/-SMA model mice. : Human molecular genetics.

Chicago

Kaifer Kevin A, Villalón Eric, O'Brien Benjamin S, Sison Samantha L, Smith Caley E, Simon Madeline E, Marquez Jose, O'Day Siri, Hopkins Abigail E, Neff Rachel, Rindt Hansjörg, Ebert Allison D and Lorson Christian L. 20200511. AAV9-mediated delivery of miR-23a reduces disease severity in Smn2B/-SMA model mice. : Human molecular genetics.

Harvard

Kaifer K. A., Villalón E., O'Brien B. S., Sison S. L., Smith C. E., Simon M. E., Marquez J., O'Day S., Hopkins A. E., Neff R., Rindt H., Ebert A. D. and Lorson C. L. (20200511). AAV9-mediated delivery of miR-23a reduces disease severity in Smn2B/-SMA model mice. : Human molecular genetics.

MLA

Kaifer Kevin A, Villalón Eric, O'Brien Benjamin S, Sison Samantha L, Smith Caley E, Simon Madeline E, Marquez Jose, O'Day Siri, Hopkins Abigail E, Neff Rachel, Rindt Hansjörg, Ebert Allison D and Lorson Christian L. AAV9-mediated delivery of miR-23a reduces disease severity in Smn2B/-SMA model mice. : Human molecular genetics. 20200511.